“…The Quality by Design (QbD) initiative launched by the US FDA suggests that quality should be built into a product based on a thorough understanding of the product and process by which it is developed and manufactured, along with an in-depth knowledge of the risks involved in manufacturing the product and procedures to mitigate those risks. Thus, it is beneficial for a pharmaceutical company to implement a process systems engineering-based approach with heavy focus on modeling in order to attain a sustainable position in the market [31,75,89]. A model-based systems approach can play a crucial role in the design, operation, evaluation, and analysis of processes because of its potential to provide better process understanding, leading to a reduction in the time and cost for the operation of the process [31,39].…”